Open label pilot phase II study of STI571 in the treatment of patients with idiopathic hypereosinophilic syndrome (HES) and eosinophilic leukemias
Phase of Trial: Phase II
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Imatinib (Primary)
- Indications Chronic myeloid leukaemia
- Focus Therapeutic Use
- 18 Nov 2006 New trial record.